- The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
-
Bartl T, Bekos C, Postl M, Alexander R, Polterauer S, Stefanie A, Richard S
- KMID: 2526289
- J Gynecol Oncol.
- 2021 Jan;32(1):e1.
- doi: 10.3802/jgo.2021.32.e1
Objective: To assess the prognostic value of the systemic immune-inflammation index (SII) in patients with vulvar cancer. Methods: Data of 130 consecutive patients who underwent primary surgical resection for vulvar cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
-
Falcone F, Maggiore ULR, Donato VD, Perrone AM, Frigerio L, Bifulco G, Polterauer S, Casadio P, Cormio G, Masciullo V, Malzoni M, Greggi S
- KMID: 2511984
- J Gynecol Oncol.
- 2020 Sep;31(5):e74.
- doi: 10.3802/jgo.2020.31.e74
Objective: ‘The Endometrial Cancer Conservative Treatment (E.C.Co.). A multicentre archive’ is a worldwide project endorsed by the Gynecologic Cancer Inter-Group, aimed at registering conservatively treated endometrial cancer (EC) patients. This... -
- CITED
-
- Close
- SHARE
-
- Close
